In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

World Bank Advises India To Curb ‘Excessive’ Use Of Health Care

This article was originally published in PharmAsia News

Executive Summary

The World Bank has warned India that its insured citizens are as much as three times more likely to be hospitalized because of a trend toward “excessive” health care in the country.

The World Bank has warned India that its insured citizens are as much as three times more likely to be hospitalized because of a trend toward “excessive” health care in the country. The bank said in a report that many costly medical treatments provide only marginal benefits and could cause harm in some cases. As India spends a greater share of public resources on medical coverage and treatment, it has an urgent need to put checks in place to avoid overuse, the bank said. (Click here for more)

"World Bank Warns Against Excessive Health Care In India" - Economic Times (India) (7/31/2014)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC087837

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel